Medical Exoskeleton Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Powered Exoskeleton, Passive Exoskeleton); By Mobility (Stationary, Mobile); By Component (Hardware, Software); By Application

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	400 Pages	BlueWeave Consulting	March, 2023	BLWC18215582

Best Price Guarantee
Price	from $4,850
Length	400 Pages
Publisher	BlueWeave Consulting
Published Date	March, 2023
SKU	BLWC18215582

Medical Exoskeleton Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Powered Exoskeleton, Passive Exoskeleton); By Mobility (Stationary, Mobile); By Component (Hardware, Software); By Application (Spinal Cord Injury, Stroke); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Global Medical Exoskeleton Market Size Zooming More Than 6X to Reach USD 2.1 Billion by 2029

Global medical exoskeleton market is flourishing because of rapid adoption of technology advancements to address the healthcare need of aging world population and people with physical disabilities.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global medical exoskeleton market size at USD 327.62 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global medical exoskeleton market size to grow at a robust CAGR of 30.2% reaching a value of USD 2,072.40 million by 2029. Major growth factors of global medical exoskeleton market include growing elderly population across the world, rising rates of medical device utilization in various industries, such as automobile, military, defense, and construction, and increasing stroke incidences. The growing number of patients with physical disabilities worldwide will drive the medical exoskeleton market. The number of people with physical disabilities is rapidly increasing as a result of car accidents, strokes, and serious injuries, which should encourage the market growth. Strokes are more common in the elderly population. According to the United States Census Bureau, the number of Americans aged 65 and up will more than double by 2050, which could boost the demand for medical exoskeleton across the countries. As a result, the demand for rehabilitation is expected to fuel the growth of the medical exoskeleton market. Also, the increasing prevalence of spinal cord injuries (SCI) is likely to increase demand across the global market during the forecast period. However, regulatory challenges for securing approvals for medical is anticipated to restrain the global medical exoskeleton market during the period in analysis.

Global Medical Exoskeleton Market – Overview

Robotics is an application of engineering aimed at replacing humans with menial duties, whereas exoskeletons are applications of robotics and bio-mechatronics aimed at augmenting humans while performing a variety of tasks. A robotic suit, powered armor, wearable machine, power jacket, and exo-frame or suit are all synonyms for the exoskeleton. The field of exoskeleton systems is constantly evolving in the current context. Exoskeletons are employed in a variety of industries, including military, civilian, and rehabilitation, to boost soldiers' travel and loading capacities, to strengthen an operator's load-handling capabilities, and to improve lost functionality and patient life. It is also used to treat musculoskeletal diseases. It aids physical therapists in training individuals with motor nerve degeneration and motor cognitive limitations. Exoskeletons are also used in rehabilitation, particularly inpatient training and movement. Wearable exoskeletons are gaining popularity due to the high need for assistive technology in the medical profession, specifically to address concerns about an aging society. Other medical issues, such as aiding trauma victims, paraplegics, spinal cord injured individuals, and rehabilitation, are also important.

Impact of COVID-19 on Global Medical Exoskeleton Market

COVID-19 pandemic adversely affected the worldwide economy, disrupting supply and demand chains and increasing unemployment rates, resulting in overall economic uncertainty. According to Ekso Bionics' 2020 annual report, revenue income decreased by 36% in FY2020 compared to FY2019 due to a substantial reduction in medical device sales. Furthermore, according to the annual report, the demand for exoskeleton-related items dropped by 38% at the start of the pandemic, resulting in 61 bookings in 2020 as opposed to 98 bookings in 2019. Also, the pandemic led to a shortage of healthcare workers, which has made it difficult for hospitals and clinics to implement medical exoskeletons that require trained personnel to operate. However, the pandemic had a positive impact due to a surge in the number of patients with respiratory issues, and medical exoskeletons were used to support their respiratory function. Also, the rising emphasis on telemedicine influenced the medical exoskeleton market. As the pandemic limited in-person consultations, telemedicine has developed as an important method for healthcare practitioners to give care remotely. As a result, there was a demand for medical exoskeletons that may be used in telemedicine consultations. Hence, medical exoskeletons with remote monitoring and control capabilities have become increasingly popular.

Global Medical Exoskeleton Market – By Type

By type, global medical exoskeleton market is bifurcated into Powered Exoskeleton and Passive Exoskeleton segments. The powered exoskeleton segment dominated the exoskeleton market in 2022 owing to the increasing use of powered exoskeleton solutions in numerous industries to improve personal safety and productivity. Furthermore, the advantages of powered technology items include smoother lifting motion, less strain on the worker's body, higher strength, force multiplier, and increased productivity.

Competitive Landscape

Major players operating in global medical exoskeleton market include Ekso Bionics, ReWalk Robotics, PARKER HANNIFIN CORP, CYBERDYNE INC., BIONIK, Rex Bionics Ltd., B-Temia, Bioventus, Hocoma, Wearable Robotics srl, ExoAtlet, Meditouch, Suit X, MarsiBionics, Rehab-Robotics Company Limited, and Myomo Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Medical Exoskeleton Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Medical Exoskeleton Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

1. Research Framework: 1.1. Research Objective; 1.2. Product Overview; 1.3. Market Segmentation
2. Executive Summary
3. Global Medical Exoskeleton Market Insights: 3.1. Application Value Chain Analysis; 3.2. DROC Analysis; 3.2.1. Growth Drivers; 3.2.1.1. Increasing Number of People with Physical Disabilities; 3.2.1.2. Advancement in Technology; 3.2.2. Restraints; 3.2.2.1. Regulatory Challenges for Securing Approvals for Medical Exoskeletons; 3.2.3. Opportunities; 3.2.3.1. Introduction of Soft Actuators; 3.2.4. Challenges; 3.2.4.1. High Equipment Cost; 3.3. Technology Advancements/Recent Developments; 3.4. Regulatory Framework; 3.5. Porter’s Five Forces Analysis; 3.5.1. Bargaining Power of Suppliers; 3.5.2. Bargaining Power of Buyers; 3.5.3. Threat of New Entrants; 3.5.4. Threat of Substitutes; 3.5.5. Intensity of Rivalry
4. Global Medical Exoskeleton Market Overview: 4.1. Market Size & Forecast, 2019–2029; 4.1.1. By Value (USD Million); 4.2. Market Share & Forecast; 4.2.1. By Type; 4.2.1.1. Powered Exoskeleton; 4.2.1.2. Passive Exoskeleton; 4.2.2. By Mobility; 4.2.2.1. Stationary; 4.2.2.2. Mobile; 4.2.3. By Component; 4.2.3.1. Hardware; 4.2.3.2. Software; 4.2.4. By Application; 4.2.4.1. Spinal Cord Injury; 4.2.4.2. Stroke; 4.2.4.3. Others; 4.2.5. By Region; 4.2.5.1. North America; 4.2.5.2. Europe; 4.2.5.3. Asia Pacific (APAC); 4.2.5.4. Latin America (LATAM); 4.2.5.5. Middle East and Africa (MEA)
5. North America Medical Exoskeleton Market: 5.1. Market Size & Forecast, 2019–2029; 5.1.1. By Value (USD Million); 5.2. Market Share & Forecast; 5.2.1. By Type; 5.2.2. By Mobility; 5.2.3. By Component; 5.2.4. By Application; 5.2.5. By Country; 5.2.5.1. United States; 5.2.5.1.1. By Type; 5.2.5.1.2. By Mobility; 5.2.5.1.3. By Component; 5.2.5.1.4. By Application; 5.2.5.2. Canada; 5.2.5.2.1. By Type; 5.2.5.2.2. By Mobility; 5.2.5.2.3. By Component; 5.2.5.2.4. By Application
6. Europe Medical Exoskeleton Market: 6.1. Market Size & Forecast, 2019–2029; 6.1.1. By Value (USD Million); 6.2. Market Share & Forecast; 6.2.1. By Type; 6.2.2. By Mobility; 6.2.3. By Component; 6.2.4. By Application; 6.2.5. By Country; 6.2.5.1. Germany; 6.2.5.1.1. By Type; 6.2.5.1.2. By Mobility; 6.2.5.1.3. By Component; 6.2.5.1.4. By Application; 6.2.5.2. United Kingdom; 6.2.5.2.1. By Type; 6.2.5.2.2. By Mobility; 6.2.5.2.3. By Component; 6.2.5.2.4. By Application; 6.2.5.3. Italy; 6.2.5.3.1. By Type; 6.2.5.3.2. By Mobility; 6.2.5.3.3. By Component; 6.2.5.3.4. By Application; 6.2.5.4. France; 6.2.5.4.1. By Type; 6.2.5.4.2. By Mobility; 6.2.5.4.3. By Component; 6.2.5.4.4. By Application; 6.2.5.5. Spain; 6.2.5.5.1. By Type; 6.2.5.5.2. By Mobility; 6.2.5.5.3. By Component; 6.2.5.5.4. By Application; 6.2.5.6. Belgium; 6.2.5.6.1. By Type; 6.2.5.6.2. By Mobility; 6.2.5.6.3. By Component; 6.2.5.6.4. By Application; 6.2.5.7. Russia; 6.2.5.7.1. By Type; 6.2.5.7.2. By Mobility; 6.2.5.7.3. By Component; 6.2.5.7.4. By Application; 6.2.5.8. The Netherlands; 6.2.5.8.1. By Type; 6.2.5.8.2. By Mobility; 6.2.5.8.3. By Component; 6.2.5.8.4. By Application; 6.2.5.9. Rest of Europe; 6.2.5.9.1. By Type; 6.2.5.9.2. By Mobility; 6.2.5.9.3. By Component; 6.2.5.9.4. By Application
7. Asia-Pacific Medical Exoskeleton Market: 7.1. Market Size & Forecast, 2019–2029; 7.1.1. By Value (USD Million); 7.2. Market Share & Forecast; 7.2.1. By Type; 7.2.2. By Mobility; 7.2.3. By Component; 7.2.4. By Application; 7.2.5. By Country; 7.2.5.1. China; 7.2.5.1.1. By Type; 7.2.5.1.2. By Mobility; 7.2.5.1.3. By Component; 7.2.5.1.4. By Application; 7.2.5.2. India; 7.2.5.2.1. By Type; 7.2.5.2.2. By Mobility; 7.2.5.2.3. By Component; 7.2.5.2.4. By Application; 7.2.5.3. Japan; 7.2.5.3.1. By Type; 7.2.5.3.2. By Mobility; 7.2.5.3.3. By Component; 7.2.5.3.4. By Application; 7.2.5.4. South Korea; 7.2.5.4.1. By Type; 7.2.5.4.2. By Mobility; 7.2.5.4.3. By Component; 7.2.5.4.4. By Application; 7.2.5.5. Australia & New Zealand; 7.2.5.5.1. By Type; 7.2.5.5.2. By Mobility; 7.2.5.5.3. By Component; 7.2.5.5.4. By Application; 7.2.5.6. Indonesia; 7.2.5.6.1. By Type; 7.2.5.6.2. By Mobility; 7.2.5.6.3. By Component; 7.2.5.6.4. By Application; 7.2.5.7. Malaysia; 7.2.5.7.1. By Type; 7.2.5.7.2. By Mobility; 7.2.5.7.3. By Component; 7.2.5.7.4. By Application; 7.2.5.8. Singapore; 7.2.5.8.1. By Type; 7.2.5.8.2. By Mobility; 7.2.5.8.3. By Component; 7.2.5.8.4. By Application; 7.2.5.9. Vietnam; 7.2.5.9.1. By Type; 7.2.5.9.2. By Mobility; 7.2.5.9.3. By Component; 7.2.5.9.4. By Application; 7.2.5.10. Rest of APAC; 7.2.5.10.1. By Type; 7.2.5.10.2. By Mobility; 7.2.5.10.3. By Component; 7.2.5.10.4. By Application
8. Latin America Medical Exoskeleton Market: 8.1. Market Size & Forecast, 2019–2029; 8.1.1. By Value (USD Million); 8.2. Market Share & Forecast; 8.2.1. By Type; 8.2.2. By Mobility; 8.2.3. By Component; 8.2.4. By Application; 8.2.5. By Country; 8.2.5.1. Brazil; 8.2.5.1.1. By Type; 8.2.5.1.2. By Mobility; 8.2.5.1.3. By Component; 8.2.5.1.4. By Application; 8.2.5.2. Mexico; 8.2.5.2.1. By Type; 8.2.5.2.2. By Mobility; 8.2.5.2.3. By Component; 8.2.5.2.4. By Application; 8.2.5.3. Argentina; 8.2.5.3.1. By Type; 8.2.5.3.2. By Mobility; 8.2.5.3.3. By Component; 8.2.5.3.4. By Application; 8.2.5.4. Peru; 8.2.5.4.1. By Type; 8.2.5.4.2. By Mobility; 8.2.5.4.3. By Component; 8.2.5.4.4. By Application; 8.2.5.5. Rest of LATAM; 8.2.5.5.1. By Type; 8.2.5.5.2. By Mobility; 8.2.5.5.3. By Component; 8.2.5.5.4. By Application
9. Middle East & Africa Medical Exoskeleton Market: 9.1. Market Size & Forecast, 2019–2029; 9.1.1. By Value (USD Million); 9.2. Market Share & Forecast; 9.2.1. By Type; 9.2.2. By Mobility; 9.2.3. By Component; 9.2.4. By Application; 9.2.5. By Country; 9.2.5.1. Saudi Arabia; 9.2.5.1.1. By Type; 9.2.5.1.2. By Mobility; 9.2.5.1.3. By Component; 9.2.5.1.4. By Application; 9.2.5.2. UAE; 9.2.5.2.1. By Type; 9.2.5.2.2. By Mobility; 9.2.5.2.3. By Component; 9.2.5.2.4. By Application; 9.2.5.3. Qatar; 9.2.5.3.1. By Type; 9.2.5.3.2. By Mobility; 9.2.5.3.3. By Component; 9.2.5.3.4. By Application; 9.2.5.4. Kuwait; 9.2.5.4.1. By Type; 9.2.5.4.2. By Mobility; 9.2.5.4.3. By Component; 9.2.5.4.4. By Application; 9.2.5.5. South Africa; 9.2.5.5.1. By Type; 9.2.5.5.2. By Mobility; 9.2.5.5.3. By Component; 9.2.5.5.4. By Application; 9.2.5.6. Nigeria; 9.2.5.6.1. By Type; 9.2.5.6.2. By Mobility; 9.2.5.6.3. By Component; 9.2.5.6.4. By Application; 9.2.5.7. Algeria; 9.2.5.7.1. By Type; 9.2.5.7.2. By Mobility; 9.2.5.7.3. By Component; 9.2.5.7.4. By Application; 9.2.5.8. Rest of MEA; 9.2.5.8.1. By Type; 9.2.5.8.2. By Mobility; 9.2.5.8.3. By Component; 9.2.5.8.4. By Application
10. Competitive Landscape: 10.1. List of Key Players and Their Types; 10.2. Global Medical Exoskeleton Company Market Share Analysis, 2022; 10.3. Competitive Benchmarking, By Operating Parameters; 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
11. Impact of Covid-19 on Global Medical Exoskeleton Market
12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis): 12.1. Ekso Bionics; 12.2. ReWalk Robotics; 12.3. PARKER HANNIFIN CORP; 12.4. CYBERDYNE INC.; 12.5. BIONIK; 12.6. Rex Bionics Ltd.,; 12.7. B-Temia; 12.8. Bioventus; 12.9. Hocoma; 12.10. Wearable Robotics srl; 12.11. ExoAtlet; 12.12. Meditouch; 12.13. Suit X; 12.14. MarsiBionics; 12.15. Rehab-Robotics Company Limited; 12.16. Myomo Inc.; 12.17. Other Prominent Players
13. Key Strategic Recommendations
14. Research Methodology: 14.1. Qualitative Research; 14.1.1. Primary & Secondary Research; 14.2. Quantitative Research; 14.3. Market Breakdown & Data Triangulation; 14.3.1. Secondary Research; 14.3.2. Primary Research; 14.4. Breakdown of Primary Research Respondents, By Region; 14.5. Assumptions & Limitations

Global Medical Exoskeleton Market Size Study & Forecast, by Type (Powered exoskeleton, Passive exoskeleton), by Mobility (Stationary, Mobile), by Component (Hardware, Software), by Application (Spinal Cord Injury, Stroke, Others) and Regional Analysis, 2023-2030

April, 2024 | Published by: Bizwit Research & Consulting | USD $4,950
Medical Exoskeleton Market Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Component (Hardware and Software), Type (Powered Exoskeleton and Passive Exoskeleton), Extremity (Lower Body Exoskeleton, Upper Body Exoskeleton, and Full Body Exoskeleton), Application (Spinal Cord Injury, Multiple Sclerosis, Stroke, Cerebral Palsy, Parkinsons Diseases, and Others), Mobility (Mobile Exoskeleton and Stationary Exoskeleton), End Users (Rehabilitation Centers, Physiotherapy Centers, Long Term Care Centers, Homecare Settings, and Others), and Geography

May, 2024 | Published by: The Insight Partners | USD $5,190
Global Medical Exoskeleton Market, By Type (Lower Body Exoskeletons, Upper Body Exoskeletons, Full Body Exoskeletons, Others (Soft Exoskeletons, Active Exoskeletons, Passive Exoskeletons)), By Mobility(Mobile Exoskeletons, Stationary Exoskeletons, Fixed Exoskeletons), By End User (Rehabilitation Centers, Hospitals, Long Term Care Centers, Homecare Settings, Others (Industrial Sites, Military)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

November, 2023 | Published by: Coherent Market Insights | USD $4,500
Spinal Cord Injury: Competitive Landscape

May, 2024 | Published by: GlobalData | USD $3,495
Spinal Cord Injury - Pipeline Insight, 2024

April, 2024 | Published by: DelveInsight | USD $2,000
Medical Exoskeleton Market Report by Component (Hardware, Software), Type (Powered Exoskeletons, Passive Exoskeletons), Extremity (Lower Extremity Medical Exoskeletons, Upper Extremity Medical Exoskeletons, Full Body), Mobility (Mobile Exoskeletons, Stationary Exoskeletons), End User (Rehabilitation Centers, Physiotherapy Centers, and Others), and Region 2024-2032

August, 2024 | Published by: IMARC Services Pvt. Ltd. | USD $3,899

PDF E-mail From Publisher:	$4,850
Multi User License (5-7 Users) Fulfilled by Publisher:	$5,750
Global Site License Fulfilled by Publisher:	$8,150

Medical Exoskeleton Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Powered Exoskeleton, Passive Exoskeleton); By Mobility (Stationary, Mobile); By Component (Hardware, Software); By Application

Research Assistance

Other tasks

Medical Exoskeleton Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Type (Powered Exoskeleton, Passive Exoskeleton); By Mobility (Stationary, Mobile); By Component (Hardware, Software); By Application

Global Medical Exoskeleton Market Size Study & Forecast, by Type (Powered exoskeleton, Passive exoskeleton), by Mobility (Stationary, Mobile), by Component (Hardware, Software), by Application (Spinal Cord Injury, Stroke, Others) and Regional Analysis, 2023-2030

Spinal Cord Injury: Competitive Landscape

Spinal Cord Injury - Pipeline Insight, 2024

Research Assistance

Other tasks